6.29
price up icon2.78%   0.17
after-market Dopo l'orario di chiusura: 6.33 0.04 +0.64%
loading

Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
44.45%
2.4094
4.3377 3.20 5.6289 2.5281
Operating Income/Loss
44.45%
-2.4094
-4.3377 -3.20 -5.6289 -2.5281
Nonoperating Income/Loss
5.27%
0.0344
0.0363 0.0237 0.023 -0.00262
Income/Loss From Continuing Operations Before Tax
44.79%
-2.375
-4.3013 -3.1764 -5.6059 -2.5308
Income/Loss From Continuing Operations After Tax
44.79%
-2.375
-4.3013 -3.1764 -5.6059 -2.5308
Net Income/Loss
44.79%
-2.375
-4.3013 -3.1764 -5.6059 -2.5308
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
86.43%
0.3701
2.7266 -7.1991 22.18 0.3766
Diluted Average Shares
86.43%
0.3701
2.7266 -7.1991 22.18 0.3766
Basic Earnings Per Share
306.33%
-6.42
-1.58 -37.33 -0.25 -6.72
Diluted Earnings Per Share
306.33%
-6.42
-1.58 -37.33 -0.25 -6.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):